Hi, what are you looking for?
Jewish Business News
Search results for "Gamida"
Business
Gamida Cell develops cellular and immune therapies for the treatment of cancer and orphan genetic diseases.
Business
Israel’s Gamida Cell, a developer of cell therapy technologies and products for transplantation and adaptive immune therapy, announced that the first person has been...
StartUps
Israel’s Gamida Cell, a developer of cell therapy technologies and products for transplantation and adaptive immune therapy, announced that orphan drug designation has been...
Business
– – Gamida Cell’s main investors may sell all their holdings to Novartis at a later stage. – The deal for the sale...
Business
– Novartis had signed an MOU to acquire the stem cell treatment company for up to $600 million. – Elbit Medical Technologies Ltd. (TASE:EMTC)...
Business
– The stem cell developer could be acquired at a company value of hundreds of millions of dollars. – Stem cell therapies developer Gamida-Cell...
Bio-Tech
Israeli research and the level of innovation have caught the attention of the world.
Blogs
Today I present to you my predictions for Israel’s medical achievements that will take place in the forthcoming new Jewish Year of 5776. They...
Blogs
In the 11th Jan 2015 edition of Israel’s good news, the highlights include: · In a chance discovery, Israeli scientists have found...
Business
– Novartis will invest $10 million in BioLineRX for a 12.8% stake. They will select three projects for joint development. – Drug development...